<DOC>
	<DOC>NCT00677950</DOC>
	<brief_summary>The trial was designed to demonstrate the comparability of the overall success rate in the OP-1 Putty treatment group to the autograft treatment group.</brief_summary>
	<brief_title>OP-1 Putty for Posterolateral Fusions</brief_title>
	<detailed_description>A controlled, open- label, blinded radiographic assessment, randomized, prospective, multicenter, multinational pivotal study in which patients with single level (L3-S1) degenerative lumbar spondylolisthesis (Grade 1 or 2) with spinal stenosis underwent decompression and spinal fusion and received OP-1 Putty or autograft. This study was a one-sided, non- inferiority trial comparing the overall success between the OP-1 Putty group and the control autograft group.</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<criteria>1. The subject has a diagnosis of Degenerative Lumbar Spondylolisthesis of Grade I or II with Spinal Stenosis demonstrated by medical history, physical examination a n d radiographic imaging. 2. The subject is a candidate for decompression and spinal fusion with the use of autograft from the iliac crest. 3. The subject requires one level lumbar fusion (L3 to S1). 4. The subject has a preoperative Oswestry Disability Index of 30100. 1. The subject has active spinal and/or systemic infection. 2. The subject is morbidly obese. 3. The subject has a known sensitivity to any component of the OP1 Putty. 4. The subject has spinal instability measured on flexion / extension radiographs of greater than 50% translation of the vertebrae and greater than or equal to 20 degrees of angular motion. 5. The subject uses tobacco or nicotine or is prescribed steroids such as cortisone.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Degenerative Disc Disease</keyword>
</DOC>